#EL P CANCER FOR CURE RAR 320 AREA SKIN#

Refractory actinic keratoses (see CPB 0567 - Actinic Keratoses Treatments).ДЄetna considers photodynamic therapy using methyl aminolevulinate medically necessary for low-risk, squamous cell carcinoma in-situ where surgery or radiation is contraindicated or impractical.ДЄetna considers photodynamic therapy using aminolevulinic acid or methyl aminolevulinate medically necessary for erythroplasia of Queyrat.ДЄetna considers photodynamic therapy experimental and investigational for other skin tumors because its effectiveness for skin tumors other than the ones listed above has not been established.ДЄetna considers photodynamic therapy using intravenous photosensitizers (e.g., porfimer sodium) experimental and investigational for these indications.ДЄetna considers photodynamic therapy medically necessary as an adjunct to stenting for palliation of inoperable cholangiocarcinoma.ДЄetna considers photodynamic therapy of cholangiocarcinoma experimental and investigational when these criteria are not met.ДЄetna considers interstitial motexafin lutetium-mediated photodynamic therapy for prostate cancer experimental and investigational because its effectiveness has not been established.ДЄetna considers photodynamic therapy forВ colon cancer experimental and investigational because its effectiveness for this indication has not been established.ДЄetna consider photodynamic therapy experimental and investigational for gastric cancer because its effectiveness for this indication has not been established.Cutaneous lesions of Bowen's disease or.Partially obstructing endobronchial non-small cell lung cancer.ДЄetna considers photodynamic therapy for lung cancer experimental and investigational when these criteria are not met.ДЄetna considers photodynamic therapy usingВ topical photosensitizers (e.g., topical methyl aminolevulinate (Metvix PDT), topical 5-fluorouracil, aminolevulinic acid (Levulan Kerastik)) medically necessary for members with any of the following non-melanoma skin tumors (including pre-malignant and primary non-metastatic skin lesions):.Microinvasive endobronchial non-small cell lung cancer at an early stage, for whom surgery and radiotherapy are not indicated or.Completely obstructing endobronchial non-small cell lung cancer or.Partially obstructing esophageal cancer, in members who can not be satisfactorily treated with Nd:YAG laser therapy.ДЄetna considers photodynamic therapy for esophageal cancer experimental and investigational when these criteria are not met.ДЄetna considers photodynamic therapy with light-activated porfimer sodium medically necessary for members with any of the following:.Completely obstructing esophageal cancer or.Barrett's esophagus carcinoma in-situ and high-grade disease in members who are not candidates for esophagectomy or.Aetna considers photodynamic therapy with light-activated porfimer sodium (Photofrin) medically necessary for esophageal cancer in members with any of the following:

El p cancer for cure rar 320 area